Dietary non-nutritive factors in targeting of regulatory molecules in colorectal cancer: an update

Ashok Kumar Pandurangan1, Norhaizan Mohd Esa

  • 1Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia

Insights

Colorectal cancer (CRC) is a common malignancy. This review explores molecular targets and compounds for CRC prevention and therapy, focusing on pathways like iNOS, COX-2, and Nrf2.

Area of Science:

  • Oncology and Cancer Research
  • Gastroenterology
  • Molecular Biology

Background:

  • Colorectal cancer (CRC) is a leading global malignancy, arising from disruptions in intestinal epithelial homeostasis.
  • Key molecular pathways implicated in CRC development include iNOS, COX-2, Nrf2, Wnt/β-catenin, Notch, and apoptosis.
  • Understanding these pathways is crucial for developing effective prevention and treatment strategies.

Purpose of the Study:

  • To review current molecular targets for colon cancer elimination.
  • To update knowledge on dietary and non-nutritional compounds for CRC prevention.
  • To explore interactions between compounds and regulatory molecules in CRC.

Main Methods:

  • Literature review of scientific articles on colorectal cancer targets and compounds.
  • Analysis of molecular pathways involved in intestinal epithelial regulation.
  • Synthesis of information on dietary and non-nutritional agents impacting CRC.

Main Results:

  • Identified several promising molecular targets (iNOS, COX-2, Nrf2, Wnt/β-catenin, Notch, apoptosis) for CRC intervention.
  • Highlighted the potential of various dietary and non-nutritional compounds.
  • Emphasized the role of these compounds in modulating regulatory molecules to prevent CRC.

Conclusions:

  • Targeting specific molecular pathways offers potential for CRC prevention and therapy.
  • Dietary and non-nutritional compounds can interact with these pathways.
  • Further research into these interactions may lead to novel CRC chemopreventive and therapeutic strategies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K